Aktieanalys

Genovis: Acquires IP rights to novel enzymes - Redeye

{newsItem.title}

Redeye Publicerad: 26 Apr 2023 07:16

Redeye looks positively upon today’s announcement that Genovis has acquired the patent rights to a unique DNA polymerase with potential applications within research, diagnostics, and forensics.

Länk till analysen i sin helhet: https://www.redeye.se/research/897079/genovis-acquires-ip-rights-to-novel-enzymes?utm_source=finwire&utm_medium=RSS

Nyheter om Genovis

Läses av andra just nu

Om aktien Genovis

Senaste nytt